JPRN-jRCT1080225285已完成1 期
A Phase I Study to Investigate the Absorption, Distribution, Metabolism and Excretion of [14C]-S-600918 Following Oral Dose Administration in Healthy Adult Male Subjects
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 30age old 至 <= 65age old（—）
- 性别
- Male
入选标准
- •Healthy male subjects
排除标准
- •Subjects who are considered ineligible for this study by the investigator or subinvestigator due to current or history of clinically significant metabolic or endocrine, cardiovascular, renal, hepatic, hematological, urological, immunological, pulmonary, respiratory or gastrointestinal disease, neurological or psychiatric disorderor, or other clinically significant diseases.
研究者
相似试验
已完成
1 期
A study to see how [14C]-S-033188 is taken up, broken down and removed from the bodyRespiratoryInfluenza, virus not identifiedInfluenza virus infectionISRCTN74587134Shionogi Ltd6
已完成
不适用
A Phase 1 study to investigate the absorption, metabolism and excretion of 14C-Orteronel (TAK-700) following a single oral administration in healthy subjects10036958Prostate cancerNL-OMON36117Millenium Pharmaceuticals6
已完成
不适用
A phase 1 study to investigate the absorption, metabolism and excretion of [14C] AT1001 (migalastat hydrochloride) following a single oral administration in healthy volunteers.NL-OMON35820Amicus Therapeutics, Inc.6
已完成
不适用
A Phase I Study to Investigate the Absorption, Metabolism, and Excretion of Radiolabeled [14C] R924548 Following Single Oral Dose Administration in Healthy Male Subjectsimmune-mediated diseasesrheuma10003816NL-OMON37118Rigel Pharmaceuticals, Inc6
已完成
不适用
A Phase 1 Study to Investigate the Absorption, Metabolism, and Excretion of 14C-PTC299 Following Multiple Oral Dose Administrations in Healthy VolunteersAcute LeukemiaNL-OMON50826PTC Therapeutics, Inc.7